Stock Price
22.51
Daily Change
0.14 0.62%
Monthly
24.91%
Yearly
146.00%
Q2 Forecast
18.09

Assertio Holdings reported $-2.92M in Net Income for its fiscal quarter ending in September of 2024.





Net Income Change Date
ANI Pharmaceuticals USD 29.49M 2.86M Mar/2026
Assertio Holdings USD -2.92M 753K Sep/2024
Aurora Cannabis CAD 1.82M 53.29M Dec/2025
Cara Therapeutics USD -5.53M 621K Sep/2025
Daiichi Sankyo JPY 86.63B 41.32B Dec/2025
Ironwood Pharmaceuticals USD 3.19M 457K Dec/2024
J&J USD 5.24B 119M Mar/2026
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Merck USD -4.24B 7.2B Mar/2026
Nektar Therapeutics USD -36.08M 978K Dec/2025
Omeros USD -32.23M 23.81M Sep/2024
Pfizer USD 2.69B 4.34B Mar/2026
Teva Pharmaceutical Industries USD 369M 111M Mar/2026